Skip to content
★ Sign in to follow
MC

METACARE Co., Ltd. Stock: price and insider trades · South Korea

메타케어

KR·Mcap ₩22BHealth Care

1 insider bought €56k of shares over the last 90 days, the latest by 이수진, filed 29 Oct 2026.

METACARE Co., Ltd.: what insiders have been doing

This page follows insider dealings at METACARE Co., Ltd. as filed with DART (FSS), a company from the Health Care sector. Over the twelve months to 31 October 2026, 7 filings were filed, from 4 insiders.

Open-market activity splits into 3 purchases and 3 sales; 2 insiders sit on the buying side and 2 insiders on the selling side. The amount is not disclosed for 6 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 major shareholder and 1 chief executive among the declarants.

The most recent open-market purchase was published on 29 October 2026, 12 days ago.

With 7 filings in twelve months, the company is in line with the median of 7 filings across the 2,655 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 7 purchases and 11 sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
66
Thresholds
n/a
Buy Volume
€139M
7 ops. · all time
Sell Volume
€21M
11 ops. · all time

Who traded when

BuySale
청담메이힐스신기술조합5 sales
메타랩스2 buys2 sales
이수진1 buy

Since the insiders bought

  • Filed 05 Aug 2024 · 827 days ago
    -21.5%
    Entry ₩4,050 · Close at T+365 ₩3,180

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 21,863 of 26,911 companies
29.7
score / 100
Value
31
Quality
28
FCF yld-28%
Earn yld2.9%
EV/EBITDA13.8x
ROE-1.4%
Gross mgn30%
Net mgn1.5%
Debt/EBITDA10.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩997
Analyst consensus
·
Income statement
Revenue₩32.8B
Gross profit₩10B30% margin
EBITDA₩5.5B17% margin
Net income₩498.2M-4.0% margin
Valuation
Beta0.62
Balance sheet & cash
Market cap₩22B
Total debt₩59.3B
Free Cash Flow-₩4.9B
Debt / Equity54%
Profitability & ownership
ROE-1.4%
ROA0.4%
% insiders51.2%
% institutions0.0%
Last declaration on 29 October 2026
Declarations66 total
  • ▲
    대표이사Executives(filed)
    €56kest.0DART
    63,199 sharesShareKRXDART:20261029000083
    Canonical exit: 27 Jan 2027 (T+90)
  • ▲
    10%이상주주Executives(filed)
    €3.2Mest.0DART
    4,878,049 sharesShareKRXDART:20260629000149
    Canonical exit: 27 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €3.2Mest.0DART
    4,878,049 sharesKRXDART:20260629000153
    Canonical exit: 27 Sept 2026 (T+90)
  • ▼
    -Executives
    0DART
    57,638,853 sharesShareKRXDART:20260507000591
  • ▼
    Executives(filed)
    0DART
    57,638,853 sharesKRXDART:20260507000594
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives
    0DART
    3,589,876 sharesKRXDART:20260304001518
  • ▼
    Related company / holdingExecutives
    €10.6Mest.0DART
    5,393,537 sharesKRXDART:20250925000464
  • ▼
    Related company / holdingExecutives(filed)
    €800kest.0DART
    372,146 sharesShareKRXDART:20250604000290
  • ▼
    Related company / holdingExecutives
    €4.2Mest.0DART
    2,005,000 sharesKRXDART:20250424000566
  • ▼
    Related company / holdingExecutives(filed)
    €4.2Mest.0DART
    2,005,000 sharesShareKRXDART:20250424000551
  • ▲
    -Executives
    0DART
    ShareKRXDART:20240812000831
    Canonical exit: 10 Nov 2024 (T+90)
  • ▲
    Executives
    0DART
    10,888,889 sharesKRXDART:20240812000833
    Canonical exit: 10 Nov 2024 (T+90)
  • ▼
    -Executives
    0DART
    ShareKRXDART:20240807000065
  • ▼
    Executives
    0DART
    46,154,281 sharesKRXDART:20240807000059
  • ●
    Executives
    0DART
    0KRXDART:20240805000345
  • ▲
    -Executives
    0DART
    ShareKRXDART:20240805000343
    Canonical exit: 3 Nov 2024 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives
    €1.0Mest.0DART
    359,437 sharesKRXDART:20240702000392
  • ▼
    Related company / holdingExecutives
    0DART
    ShareKRXDART:20240702000340
  • ▲
    Executives
    €132.3Mest.0DART
    46,154,281 sharesKRXDART:20240628000687
    Canonical exit: 19 Sept 2024 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20240627000098
  • ●
    Executives
    0DART
    0KRXDART:20231027000397
  • ●
    Related company / holdingExecutives
    0DART
    ShareKRXDART:20231027000411
  • ●
    Related company / holdingExecutives
    0DART
    ShareKRXDART:20230829000603

25 of 66 declarations

About METACARE Co., Ltd.

MetaCare is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations